Franca Falzetti

University of Perugia — Italy

Medicine · Health Sciences

37h-index8.1kcitations204works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Lymphocytic Leukemia Research(68), Hematopoietic Stem Cell Transplantation(52), Acute Myeloid Leukemia Research(35), Immune Cell Function and Interaction(31), Chronic Myeloid Leukemia Treatments(31)

Publications203 total

A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect
Leukemia·2023· 8 citedOpen Access
Figure S3 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
2023Open Access
Data from Endothelial Differentiation of Hematopoietic Stem and Progenitor Cells from Patients with Multiple Myeloma
2023Open Access
Figure S9 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
2023Open Access
Figure S6 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
2023Open Access
Figure S4 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
2023Open Access
Supplementary Figure S1 from Endothelial Differentiation of Hematopoietic Stem and Progenitor Cells from Patients with Multiple Myeloma
2023Open Access
Figure S5 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
2023Open Access
Data from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
2023Open Access
Supplementary Tables from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
2023Open Access
Figure S10 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
2023Open Access
Data from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
2023Open Access
Figure S9 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
2023Open Access
Supplementary Figure Legend from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
2023Open Access
Figure S8 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
2023Open Access
Data from Endothelial Differentiation of Hematopoietic Stem and Progenitor Cells from Patients with Multiple Myeloma
2023Open Access
Figure S3 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
2023Open Access
Supplementary Tables from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
2023Open Access
Figure S7 from Decreased NOTCH1 Activation Correlates with Response to Ibrutinib in Chronic Lymphocytic Leukemia
2023Open Access
Supplementary Figure S1 from Endothelial Differentiation of Hematopoietic Stem and Progenitor Cells from Patients with Multiple Myeloma
2023Open Access
page 1 of 11Next →

Frequent Co-authors

Maria Paola Martelli(29), Mauro Di Ianni(29), Beatrice Del Papa(18), Paolo Sportoletti(18), Franco Aversa(14), Antonio Tabilio(14), Alessandra Carotti(13), Stefano Baldoni(13), Emanuela Rosati(13), Andrea Velardi(12), Loredana Ruggeri(11), Brunangelo Falini(11), Debora Cecchini(10), Adelmo Terenzi(9), Antonio Pierini(9), P Marconi(9), Tiziana Zei(8), Filomena De Falco(8), Roberta Iacucci Ostini(7), Isabella Screpanti(7)